Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

15-deoxy-Delta(12,14)-prostaglandin J(2) reduces albumin-induced arthritis in temporomandibular joint of rats

Full text
Author(s):
Quinteiro, Mariana Silva [1] ; Napimoga, Marcelo Henrique [2] ; Macedo, Cristina Gomes [1] ; Freitas, Fabiana Furtado [1] ; Abdalla, Henrique Balassini [1] ; Bonfante, Ricardo [1] ; Clemente-Napimoga, Juliana Trindade [1]
Total Authors: 7
Affiliation:
[1] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Lab Orofacial Pain, Piracicaba, SP - Brazil
[2] Sao Leopoldo Mandic Inst & Res Ctr, Lab Immunol & Mol Biol, Campinas, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: European Journal of Pharmacology; v. 740, p. 58-65, OCT 5 2014.
Web of Science Citations: 14
Abstract

The aim of this study was to evaluate the peripheral effect of 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) in albumin-induced arthritis in temporomandibular joint (TMJ) of rats. Antigen-induced arthritis (ALA) was generated in rats with methylated bovine serum albumin (mBSA) diluted in complete Freund's adjuvant. Pretreatment with an intra-articular injection of 15d-PGJ(2) (100 ng/TMJ) before mBSA intra-articular injection (10 mu g/TMJ) (challenge) in immunized rats significantly reduced the albumin-induced arthritis inflammation. The results demonstrated that 15d-PGJ(2) was able to inhibit plasma extravasation, leukocyte migration and the release of inflammatory cytokines IL-6, IL-12, IL-18 and the chemokine CINC-1 in the TMJ tissues. In addition, 15d-PGJ(2) was able to increase the expression of the anti-adhesive molecule CD55 and the anti-inflammatory cytokine IL-10. Taken together, it is possible to suggest that 15d-PGJ2 inhibit leukocyte infiltration and subsequently inflammatory process, through a shift in the balance of the pro- and anti-adhesive properties. Thus, 15d-PGJ2 might be used as a potential anti-inflammatory drug to treat arthritis-induced inflammation of the temporomandibular joint. (C) 2014 Published by Elsevier B.V. (AU)

FAPESP's process: 11/00683-5 - Evaluation of the peripheral effect of 15d-PGJ2 on rheumatoid arthritis-induced inflammatory response in the TMJ of rats
Grantee:Juliana Trindade Clemente Napimoga
Support Opportunities: Regular Research Grants